2019
DOI: 10.1155/2019/1095215
|View full text |Cite
|
Sign up to set email alerts
|

Novel Haplotype Indicator for End-Stage Renal Disease Progression among Saudi Patients

Abstract: Background. End-stage renal disease (ESRD) is the result of hypertensive nephrosclerosis and chronic glomerular diseases and is associated with high morbidity and mortality. There are strong heritable components in the manifestation of the disease with a genetic predisposition to renal disorders, including focal segmental glomerulosclerosis and arterionephrosclerosis. Recent studies in genetics have examined modifiable risk factors that contribute to renal disease, and this has provided a deep insight into pro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 32 publications
0
1
0
Order By: Relevance
“…In normal kidney cells, CST3 (or cystatin C) was mainly found to be expressed in vascular smooth muscle cells and mesangial cells. It mapped in the genome near polymorphisms associated with an increased risk of developing end-stage renal disease, possibly followed by FSGS complications (49). The link between the expression of fibronectin 1, the TGF-beta signaling pathway, and chronic progressive kidney disease (50) was confirmed as being restricted to the vascular smooth muscle cells and mesangial cell subpopulation.…”
Section: Online Results Visualization and The Development Of An Interamentioning
confidence: 95%
“…In normal kidney cells, CST3 (or cystatin C) was mainly found to be expressed in vascular smooth muscle cells and mesangial cells. It mapped in the genome near polymorphisms associated with an increased risk of developing end-stage renal disease, possibly followed by FSGS complications (49). The link between the expression of fibronectin 1, the TGF-beta signaling pathway, and chronic progressive kidney disease (50) was confirmed as being restricted to the vascular smooth muscle cells and mesangial cell subpopulation.…”
Section: Online Results Visualization and The Development Of An Interamentioning
confidence: 95%